Related Experiment Video
Updated: Jul 12, 2025

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Effects of Type 1 Diabetes Mellitus on Linear Growth: A Comprehensive Review
Indrayani Jadhav1, Swarupa Chakole2
1Medicine and Surgery, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Wardha, IND.
Insights
Type 1 diabetes mellitus (T1DM) negatively impacts children's growth, often causing short stature, particularly in girls. Optimal insulin therapy and new technologies may improve growth patterns in affected children.
Area of Science:
- Pediatric Endocrinology
- Metabolic Disorders
- Growth and Development
Background:
- Type 1 diabetes mellitus (T1DM) significantly affects pediatric growth.
- Metabolic control and disease duration are critical factors influencing growth outcomes.
- Children with T1DM exhibit growth hormone (GH)-insulin-like growth factor-1 (IGF-1) axis anomalies.
Purpose of the Study:
- To review the current understanding of impaired height in children with T1DM.
- To explore the impact of hormonal interactions on growth in T1DM.
- To assess the effects of different insulin therapies and emerging technologies on growth.
Main Methods:
- Literature review of studies on T1DM and pediatric growth.
- Analysis of hormonal regulation of growth, including GH-IGF-1 and sex hormone axes.
- Evaluation of treatment outcomes with various insulin regimens and technologies.
Main Results:
- Children with T1DM may experience shorter stature, with some studies indicating this in girls or both sexes.
- Final height in boys remained unchanged, but a slight reduction was noted in girls.
- Insulin therapy, particularly good basal insulin during puberty, influenced height, while continuous subcutaneous insulin injection had no effect.
Conclusions:
- T1DM poses a significant risk for impaired linear growth in children.
- Hormonal imbalances, especially involving the GH-IGF-1 and sex hormone axes, contribute to growth disturbances.
- Advanced insulin therapies and new technologies show promise for optimizing growth in prepubertal children with T1DM.
Abstract:
Type 1 diabetes mellitus (T1DM) has a significant effect on the growth of children. The disease has a negative effect on growth when considered in relation to the time period and metabolic control. Studies in this review have suggested debilitated growth in children with T1DM and have a few anomalies in the growth hormone (GH)-insulin-like growth factor-1 (IGF-1) axis when compared to fit children. Some studies show that children with T1DM were taller before the onset of the disease and during early diagnosis. Moreover, the linear growth depends on the interaction between the gonadotropin hormone, luteinizing hormone (LH), follicle-stimulating hormone (FSH), and sex steroid hormones axis and GH-IGF-1; there's a rise in GH during puberty, which has an effect on the estrogen and testosterone, which leads to the pulsatile secretion of GH, this increment leads to insulin resistance. These studies suggest short stature in girls, and some suggest in both. The final height in boys was unchanged, but a slight decline was observed in girls. This review aims to provide the latest understanding of impaired height in children with T1DM. The most accepted and effective treatment of impaired growth is the administration of long-acting insulin or continuous rapid-acting insulin. However, height was affected by the administration of good basal insulin at puberty and was unaffected by the continuous subcutaneous insulin injection. Hence, new technologies are the therapeutic regimen in children, especially the prepubertal age group; it will be interesting to see their effects on growth patterns in these children with T1DM.
More Related Videos
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
06:21Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid
Published on: April 7, 2023
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Symptoms, Diagnosis, and Complications
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...